adjupanrix (previously pandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted) glaxosmithkline biologicals)
glaxosmithkline biologicals s.a. - split influenza virus, inactivated, containing antigen: a/vietnam/1194/2004 (h5n1) like strain used (nibrg-14) - influenza, human, immunization, disease outbreaks - vaccines, - prophylaxis of influenza in an officially declared pandemic situation. pandemic influenza vaccine should be used in accordance with official guidance.,
dovato 50/300
glaxosmithkline nz limited - dolutegravir sodium 52.6mg equivalent to dolutegravir 50mg; ; ; lamivudine 300mg; - film coated tablet - active: dolutegravir sodium 52.6mg equivalent to dolutegravir 50mg lamivudine 300mg excipient: magnesium stearate mannitol microcrystalline cellulose opadry white oy-s-28876 povidone purified water sodium starch glycolate sodium stearyl fumarate - indicated for the treatment of human immunodeficiency virus (hiv-1) infection in adults and adolescents from 12 years of age weighing at least 40kg, who have no known or suspected resistance to either antiretroviral component.
zyrtec drops oral
aesica pharmaceuticals s.r.l. - cetirizine (cetirizine dihydrochloride) - drops oral - 10mg/ml
priorix-tetra
glaxosmithkline pte ltd - live attenuated measles virus (schwarz strain); live attenuated mumps virus (rit4385 strain); live attenuated rubella virus (wistar ra 27/3 strain); live attenuated varicella virus (oka strain) - injection, powder, lyophilized, for solution - ≥ 10 3.0 ccid50 /dose - live attenuated measles virus (schwarz strain) ≥ 10³ ccid50/dose; live attenuated mumps virus (rit4385 strain) ≥ 10⁴·⁴ ccid50/dose; live attenuated rubella virus (wistar ra 27/3 strain) ≥ 10³ ccid50/dose; live attenuated varicella virus (oka strain) ≥ 10³·³ pfu/dose
infanrix hexa vaccine
glaxosmithkline pte ltd - diphtheria toxoid; filamentous haemagglutinin; hepatitis b surface antigen (purified); hib purified capsular polysaccharide bound to tetanus toxoid; pertactin (69 kda omp); pertussis toxoid; poliovirus type 1 (inactivated); poliovirus type 2 (inactivated); poliovirus type 3 (inactivated) - injection - min 30 iu/0.5 ml - diphtheria toxoid min 30 iu/0.5 ml; filamentous haemagglutinin 25 mcg/0.5 ml; hepatitis b surface antigen (purified) 10 mcg/0.5 ml; hib purified capsular polysaccharide bound to tetanus toxoid 10 mcg/0.5 ml; pertactin (69 kda omp) 8 mcg/0.5 ml; pertussis toxoid 25 mcg/0.5 ml; poliovirus type 1 (inactivated) 40 du/0.5 ml; poliovirus type 2 (inactivated) 8 du/0.5 ml; poliovirus type 3 (inactivated) 32 du/0.5 ml
flixonase allergy 50mcg/actuation nasal spray, suspension
glaxosmithkline export limited - fluticasone propionate 0.5 mg - nasal spray, suspension
motens 2mg tablets
glaxosmithkline uk ltd - lacidipine - oral tablet - 2mg
motens 4mg tablets
glaxosmithkline uk ltd - lacidipine - oral tablet - 4mg
imigran 50mg tablets
glaxosmithkline uk ltd - sumatriptan succinate - oral tablet - 50mg
adartrel 500microgram tablets
glaxosmithkline uk ltd - ropinirole hydrochloride - oral tablet - 500microgram